How Worrisome Is Ocugen’s Latest Bad News?
Investors don’t need to be too concerned about the FDA’s clinical hold on a Covaxin study– for now.
Mindfully Curated
Investors don’t need to be too concerned about the FDA’s clinical hold on a Covaxin study– for now.
High-growth stocks have taken a big haircut in the past few months after an incredible 2020.
The pandemic has changed many things, including this detrimental retail trend that has reversed course to head in a positive direction.
If your 401(k) isn’t on par with your peers, you need to know it.
Axon and founder Patrick Smith are riding high.
The tech giant’s stock is hovering near an all-time high.
Lucid is in the hot seat as regulators investigate and insiders sell stock.
These companies’ stock prices are down over double digits so far in 2021.
Consider letting professional investors manage your funds.
Don’t make it complicated. Your long-term holdings should come from industries that are truly timeless, like banking.
These three companies could crush any cryptocurrency’s return over the next decade.
This fintech posted strong results in the third quarter but remains undervalued.
Been missing out on other hot growth trends? Get real.
Tesla has had a phenomenal year, but it’s more affordable than you may think.
These companies have had a strong 2021, with plenty of room to grow.
Ethereum is one of the strongest (and priciest) cryptocurrencies. Is there still time to buy?
The tech titan has a lot going for it.
These two stocks could change your retirement.
Find out if you will get the maximum Social Security benefit next year.
Fear of missing out could be warranted when it comes to these two.